New test and early treatment aim to save babies from sickle cell disease
NCT ID NCT07488520
Summary
This study aims to see if using a new, portable screening device to find sickle cell disease in newborns, followed by starting a full package of early care, can improve health outcomes for babies. Researchers will enroll 120 babies in Côte d'Ivoire, screen them, and provide treatments like preventive antibiotics, malaria drugs, and a medication called hydroxyurea to those who test positive. They will track the babies' health for over three years to see if this approach reduces hospital visits, serious complications, and deaths from the disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE (SCD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Yopougon SCD Center of Excellence
Yopougon, Côte d’Ivoire
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.